LEADER 02278nam  2200541Ia 450 
001 9910781235203321
005 20230617042639.0
010   $a0-309-55716-X
035   $a(CKB)2550000000038279
035   $a(EBL)3376999
035   $a(SSID)ssj0000139796
035   $a(PQKBManifestationID)11136618
035   $a(PQKBTitleCode)TC0000139796
035   $a(PQKBWorkID)10029258
035   $a(PQKB)10378495
035   $a(MiAaPQ)EBC3376999
035   $a(Au-PeEL)EBL3376999
035   $a(CaPaEBR)ebr10062923
035   $a(OCoLC)923267227
035   $a(EXLCZ)992550000000038279
100   $a20050330d2004      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aDiscovery of antivirals against smallpox$b[electronic resource] /$fCommittee on Transforming Biological Information into New Therapies: A Strategy for Developing Antiviral Drugs for Smallpox ; Board of Life Science, Division on Earth and Life Studies and Institute of Medicine
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (11 p.)
300   $a"Executive Summary"--Publisher's title screen.
300   $aCurrently not published in a print format, available online only.
327   $a""FRONT MATTER""; ""COMMITTEE ON TRANSFORMING BIOLOGICAL INFORMATION INTO NEW THERAPIES: A STRATEGY FOR DEVELOPING ANTIVIRAL DRUGS FOR SMALLPOX""; ""BOARD ON LIFE SCIENCES""; ""ACKNOWLEDGEMENTS""; ""RECOGNITION OF REVIEWERS""; ""EXECUTIVE SUMMARY""
330   $a"Institute of Medicine and National Research Council of the National Academies."
606   $aSmallpox$xPrevention and control$zUnited States
606   $aSmallpox vaccine
606   $aSmallpox$xResearch
615  0$aSmallpox$xPrevention and control
615  0$aSmallpox vaccine.
615  0$aSmallpox$xResearch.
676   $a614.521
712 02$aBoard of Life Sciences.$bCommittee on Transforming Biological Information into New Therapies: A Strategy for Developing Antiviral Drugs for Smallpox.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781235203321
996   $aDiscovery of antivirals against smallpox$93694799
997   $aUNINA